Case Study: How Market Insight Drove a Successful Product Launch
Market insights are crucial to the success of a pharmaceutical product launch. Launching a new therapy in an industry where patient needs, regulatory requirements, market competition and healthcare policies are constantly changing requires much more than scientific innovation. It requires a detailed understanding of the market, stakeholders and commercial opportunities. This case study shows how a structured market insights strategy can have an impact on product development, improve commercialization plans and lead to a successful launch. This is a hypothetical example but is representative of typical best practices across the pharmaceutical industry.
Why Market Insights Are Key Before Launching a Product
Developing a new pharmaceutical product is expensive. Investment is required in research, development, regulatory approval, manufacturing and commercialization. Without good market intelligence, companies risk targeting the wrong patient population, misjudging market demand, or developing messaging that does not resonate with healthcare professionals.
Market insights help companies understand patient needs, physician preferences, competitor activities, reimbursement issues and healthcare trends. These insights help reduce uncertainty and allow more confident business decisions across the lifecycle of the product.
The Challenge
A novel therapy for a chronic health condition was developed by a mid-sized pharmaceutical company. Despite the good safety and efficacy data from the clinical trial, the commercial team knew that scientific success alone would not ensure market adoption.
There were a number of challenges to be overcome before launch:
Intense competition from existing therapies
Limited awareness amongst health care providers
Unawareness of patient’s treatment choices
Complicated reimbursement rules
Variations in target market healthcare practices
Before it sealed its commercialization strategy, the company took a decision to invest in a massive market insights program.
The Market Research Strategy
The market insights team combined data from multiple sources to create a holistic view of the healthcare landscape.
Research activities comprised:
Conversations with doctors and health experts
Patient surveys, focus groups
Competitive intelligence report
Market access assessments
Reviews of real-world evidence
Analysis of healthcare claims
Monitoring social media and patient communities
Rather than relying on a single research tool, the company combined qualitative and quantitative data to form an overall picture of the market.
Key Insights Uncovered
The research identified a number of key findings that had a significant impact on the launch strategy.
Better Understanding of Patient Needs
Interviews of patients showed that convenience of treatment and quality of life were as important as clinical effectiveness. Many patients were concerned about treatment schedules, side effects and long-term adherence.
The company applied these lessons to its educational materials and marketing campaigns, focusing on the benefits of the patient experience as well as clinical benefits.
Factors in Physician Decision Making
Key influences on prescribing decisions by healthcare professionals identified were clear clinical evidence, real-world effectiveness and practical patient support programmes.
The company thus expanded its physician education efforts and created additional clinical resources to support healthcare providers post-launch.
Competitive Landscape
Competitive intelligence showed the current products were very efficacy-centric, but not as much on patient experience and long-term disease management.
This was an opportunity for the company to differentiate its therapy by emphasizing the all-around patient support, a better experience of treatment and continued care.
Market Access Strategy
Payer and health care decision-maker research underscored the need to demonstrate long-term value with improved patient outcomes and reduced health care utilization.
The company bolstered its market access strategy by integrating health economic evidence and real-world data into reimbursement discussions.
The Launch Strategy
With this market insight, the organization refined its commercialization plan prior to product launch.
The major improvements were:
More focused physician education programs
Patient-centered communication materials
Improved patient support services
Enhanced market access documentation
Better competitive position
Messaging relevant to various stakeholder groups
The launch strategy was based on evidence gathered from market research for every aspect, rather than assumptions.
The Outcomes
After the product was launched, the company saw good acceptance in the market in its target regions. Healthcare professionals responded positively to the educational resources and patients liked the additional support programs and easier-to-understand treatment information.
The insights-led approach also improved discussions with healthcare payers, as it provided clear evidence of the clinical and economic value of the therapy. Before launch, teams had built continuous monitoring systems internally which meant they could react quickly to feedback from the market.
Every pharmaceutical launch is different but this case demonstrates how investment in high quality market insights can reduce uncertainty, improve decision making and boost commercial performance.
What Pharmaceutical Companies Can Do
Successful product launches are based on an understanding of the market prior to the launch of a new therapy. Organizations that embed market research throughout the product development process are better positioned to identify risks, understand stakeholder expectations and develop strategies that meet real world healthcare needs.
A stronger foundation for commercial success is built when patient insights, physician feedback, competitive intelligence, real-world evidence and market access research are integrated. Market insights should not be considered a one-time research activity, but a continuous process that feeds an informed decision making along the product lifecycle.
Pharma Insights Conference Overview
Pharma Insights Conference is the leading event for pharmaceutical executives, market researchers, healthcare professionals, regulators and technology innovators to hear the latest trends affecting the life sciences industry. The conference offers expert keynote presentations, panel discussions, networking opportunities, and interactive learning sessions that provide valuable insights into pharmaceutical market research, product commercialization, market access, clinical development, artificial intelligence and healthcare innovation. It is a great platform for professionals to exchange knowledge, discover best practices and strengthen the strategies that are driving successful pharmaceutical product launches.